Advertisement
News
Subscribe to MDT Magazine News

Cellceutix settles with former CEO Evans

February 15, 2011 4:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Cellceutix Corp., a biotechnology firm in Beverly, has agreed to buy 4.6 million common stock shares, valued at about $1 million, from former CEO George W. Evans, who resigned in November amid a pay dispute with the company.

Cayenne Medical, Inc. Launches AperFix® II

February 15, 2011 4:36 am | by Bio-Medicine.Org | Comments

SCOTTSDALE, Ariz., Feb. 15, 2011 /- Cayenne Medical, Inc., a private sports medicine device company, announces the launch of AperFix® II, its second generation soft tissue repair device for multi-ligament repairs of the knee. The announcement was made today at the 2011 American...

TOPICS:

Lanx, Inc. Announces Launch of Epicâ„¢ Anterior Thoracolumbar Plating System

February 15, 2011 4:36 am | by Bio-Medicine.Org | Comments

BROOMFIELD, Colo., Feb. 15, 2011 /- Lanx, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, today announced the launch of its Epic™ Anterior Thoracolumbar Plating System (Epic™ System) at the 2011...

TOPICS:
Advertisement

Patient-Derived Heart Cells Mimic Disease

February 15, 2011 4:34 am | by Massachusetts Institute of Technology | Comments

The cells point to new potential therapies for an inherited heart defect.

TOPICS:

Governor Corbett Announces at Least 80 New Jobs in Lehigh Valley with Pharmaceutical Company's Purchase, Renovation of Former Amcor Site

February 15, 2011 4:34 am | by Bio-Medicine.Org | Comments

HARRISBURG, Pa., Feb. 15, 2011 /PRNewswire-USNewswire/ -- Governor Tom Corbett today announced that the global pharmaceutical company Daiichi Sankyo Inc. will create more than 80 jobs in the Lehigh Valley with the establishment of its first U.S. manufacturing and packaging operation....

TOPICS:

Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer

February 15, 2011 4:34 am | by Bio-Medicine.Org | Comments

SAN JOSE, Calif., Feb. 15, 2011 /- Baxano, Inc. ( w w w.b a x a no. c om ) today announced the addition of George A. Harter, Jr. to the executive team at Baxano, Inc. As Chief Financial Officer, Mr. Harter will be responsible for Finance, Administration and Human Resources. Mr. Harter...

TOPICS:

Boston Scientific Establishes Endowment for Donald S. Baim, M.D., Scholarship at Yale School of Medicine

February 15, 2011 4:34 am | by Bio-Medicine.Org | Comments

NATICK, Mass., Feb. 15, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that it has established a $1.7 million endowment to fund the "Donald S. Baim, M.D., '75 Scholarship Fund" for Yale School of Medicine.  This scholarship fund will honor the late interventional...

TOPICS:

U.S. Task Force Mammogram Recommendations Questioned

February 15, 2011 4:33 am | by Diagnostic Imaging | Comments

HealthDay News - Study finds starting at younger age and screening more frequently results in more lives saved.

TOPICS:
Advertisement

Radiation Exposure After Heart Attack May Raise Cancer Risk

February 15, 2011 4:33 am | by Diagnostic Imaging | Comments

HealthDay News - Dose-dependent relationship found between low-dose ionizing radiation exposure, cancer risk

TOPICS:

PositiveID Corporation Partners With Wireless Technology Leaders at Connected Development to Complete Final Development of iglucose

February 15, 2011 4:32 am | by PositiveID | Comments

PositiveID Corporation Partners With Wireless Technology Leaders at Connected Development to Complete Final Development of iglucose

TOPICS:

Vermillion Announces $21.8 Million Public Offering

February 15, 2011 4:32 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Feb. 15, 2011 /- Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics company, announced today that it has agreed to sell 4,000,000 shares of its common stock in an underwritten public offering at a price of $5.45 per share.  The Company expects that the net...

TOPICS:

Class II Medical Device Recall: Triad Group, Triad Sterile Lubricating Jelly

February 15, 2011 4:30 am | by U.S. Food & Drug Administration | Comments

Reason for Recall: This product may not be sterile. Patients, who are immuno-compromised, such as those with diabetes, cancer and certain other chronic diseases, may be at potential risk for infection.

TOPICS:

Nfocus Neuromedical, Inc. Lunaâ„¢ Aneurysm Embolization System Receives CE Mark

February 15, 2011 2:34 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., Feb. 15, 2011 /- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, announced today that its Luna™ Aneurysm Embolization System (AES) received CE Mark for the treatment of patients...

TOPICS:

Covidien to Launch TurboHawk(TM) Plaque Excision System for Small Vessels

February 15, 2011 2:33 am | by Covidien | Comments

New system offers greater efficiency and more consistent performance for physicians MANSFIELD, Mass., Feb 15, 2011 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it will launch the TurboHawk(TM) Plaque Excision System for...

TOPICS:

Orascom Telecom, Mobinil and Great Connection Collaborate to Launch Mobile Babyâ„¢ Service in Egypt

February 14, 2011 11:33 pm | by Bio-Medicine.Org | Comments

BARCELONA, Spain, Feb. 15, 2011 /- Orascom Telecom and Mobinil, in collaboration with Great Connection, today announced the launch of a pilot project to bring mobile DICOM sonar images remote diagnostics to pregnant women in Egypt.   Mobile Baby™ service, offered in Egypt by...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading